Assessment of the alpha 7 nicotinic acetylcholine receptor as an imaging marker of cardiac repair-associated processes using NS14490

Victoria J. M. Reid,Wesley K. X. McLoughlin,Kalyani Pandya,Holly Stott,Monika Iškauskienė,Algirdas Šačkus,Judit A. Marti,Dominic Kurian,Thomas M. Wishart,Christophe Lucatelli,Dan Peters,Gillian A. Gray,Andrew H. Baker,David E. Newby,Patrick W. F. Hadoke,Adriana A. S. Tavares,Mark G. MacAskill
DOI: https://doi.org/10.1186/s13550-023-01058-2
IF: 3.434
2024-01-13
EJNMMI Research
Abstract:Cardiac repair and remodeling following myocardial infarction (MI) is a multifactorial process involving pro-reparative inflammation, angiogenesis and fibrosis. Noninvasive imaging using a radiotracer targeting these processes could be used to elucidate cardiac wound healing mechanisms. The alpha7 nicotinic acetylcholine receptor (ɑ7nAChR) stimulates pro-reparative macrophage activity and angiogenesis, making it a potential imaging biomarker in this context. We investigated this by assessing in vitro cellular expression of ɑ7nAChR, and by using a tritiated version of the PET radiotracer [ 18 F]NS14490 in tissue autoradiography studies.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?